Marla Kessler Net Worth & Insider Trades

Marla Kessler - Director, Ironwood Pharmaceuticals Inc

As of June 22, 2023

What is Marla Kessler's Net Worth?

The current estimated net worth of Ironwood Pharmaceuticals Inc's Director, Marla Kessler, is estimated to be about $597.01K . Marla Kessler owns about 84,148 units of Ironwood Pharmaceuticals Inc common stock. In the last 4 years at Ironwood Pharmaceuticals Inc, Marla Kessler has sold an estimated value of $88.66K worth.

What is Marla Kessler's Past Insider Trading?

Marla Kessler's largest sale order was 7,610 units , worth over $88.66K on June 16, 2022. In total, Marla Kessler has made about 7 transactions over 4 years of their time at Ironwood Pharmaceuticals Inc. Marla Kessler usually trades in June, with the busiest year in 2022 and 2019.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Marla Kessler

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Marla Kessler's' Mailing Address?

  • Mailing address is C/o Ironwood Pharmaceuticals, Inc. 100 Summer Street, Suite 2300 Boston MA 02110 MA

Ironwood Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Mark Mallon* 2020 $801,173 - $5,423,731 - $585,169 $11,040 $6,821,113
Mark Mallon* 2019 $750,000 $880,000 $3,692,810 $3,804,331 $797,063 $144,596 $10,068,800
Mark Mallon* 2018 - - - - - - -
Gina Consylman 2020 $512,751 - $1,676,402 - $264,652 $11,040 $2,464,845
Gina Consylman 2019 $480,000 $250,000 $1,467,731 $888,546 $358,800 $8,502 $3,453,579
Gina Consylman 2018 $415,000 - $782,385 $501,764 $207,500 $8,040 $1,914,688
Thomas McCourt* 2020 $576,120 - $2,465,327 - $357,409 $11,040 $3,409,896
Thomas McCourt* 2019 $511,250 - $1,760,143 $2,370,159 $454,272 $8,502 $5,104,327
Thomas McCourt* 2018 $465,000 - $549,641 $869,479 $232,500 $34,002 $2,150,622
Jason Rickard 2020 $473,314 - $1,479,191 - $258,338 $11,040 $2,221,883
Jason Rickard 2019 - - - - - - -
Jason Rickard 2018 - - - - - - -
Michael Shetzline, M.D., Ph.D. 2020 $464,681 $100,000 $1,121,001 - $194,558 $11,040 $1,891,310
Michael Shetzline, M.D., Ph.D. 2019 - - - - - - -
Michael Shetzline, M.D., Ph.D. 2018 - - - - - - -
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1446847/000104746921001006/a2243150zdef14a.htm

What are Ironwood Pharmaceuticals Inc's Past Insider Trades?

Ironwood Pharmaceuticals Inc's most recent insider trade came on September 18, 2023 by Kumar Sravan Emany who bought 36,072 units worth $300.12K . In the last 13 years, insiders at Ironwood Pharmaceuticals Inc have sold an estimated value of $119.37M and bought an estimated value of $42.4M worth of shares. Insider trading is most common in June, with the busiest year in 2019. The most active traders at the company are Mark Currie, Director,  Thomas McCourt, Chief Executive Officer,  and Bryan E Roberts, Director .

IRONWOOD PHARMACEUTICALS INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...